Cadence Pharmaceuticals, Inc. Reports First Quarter 2013 Financial Results
5/3/2013 6:29:47 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, May 2, 2013 -- /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.